Dr. Leena Bondili, MD

Dr. Bondili practices at Hmhmg Specialty Care in Hackensack, New Jersey.

Dr. Bondili's NPI, 1255817649, was assigned on July 18, 2018. Dr. Bondili holds New Jersey license 25MA10665600.

Dr. Bondili's primary practice is Hmhmg Specialty Care, at 360 Essex St, Hackensack, NJ 07601 in Bergen County. The practice phone is (732) 807-0800.

Dr. Bondili's primary practice is Hmhmg Specialty Care in Hackensack, New Jersey. Dr. Bondili is also affiliated with JFK University Medical Center. The medical group on file is Hackensack Meridian Medical Group. Dmand AI also links Dr. Bondili to 1 more hospital, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bondili practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Bondili's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Bondili is licensed in New Jersey.

CMS data shows 447 Medicare services from Dr. Bondili across 4 procedure codes in 2024, for 81 Medicare patients. Medicare paid $17,187 for them. Every service was in an office.

CMS counts 81 Medicare patients who saw Dr. Bondili in 2024. The largest group is 75 to 84, with 29 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 2.36, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bondili's median patient age at 64, with 83% women.

In 2024, Dr. Bondili wrote 364 Medicare Part D claims for 60 patients. 69% of them were for generic drugs. CMS names the drug for 158 of them, across 7 drugs with 11 or more claims each, at $122,321 in total drug cost. In 2023, CMS named 336 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Bondili for performance year 2024, reported as part of a group. Dr. Bondili accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 7 papers to Dr. Bondili, published from 2020 to 2022. 2022 was the busiest year, with 5. Dr. Bondili has published most often in Cureus. Dr. Bondili's most frequent co-authors are Michael Maroules, MD, Amany Abu Hanoud, MD and Hamdallah Ashkar, MD.

CMS Open Payments shows 391 general payments to Dr. Bondili from 54 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 74% of the total. Novartis Pharmaceuticals Corporation paid the most, $1,995.